| Autor: |
Lip, P. L., Cikatricis, P., Sarmad, A., Damato, E. M., Chavan, R., Mitra, A., Elsherbiny, S., Yang, Yit, Mushtaq, B. |
| Jazyk: |
angličtina |
| Rok vydání: |
2017 |
| ISSN: |
1476-5454 |
| Popis: |
PurposeVarious combination treatment regimens have been tried to improve the short-term efficacy of intravitreal monotherapy for the treatment of macular oedema (MO) secondary to retinal vein occlusion (RVO). Our study introduces the RandOL protocol (Ranibizumab and Ozurdex with Laser photocoagulation) of initial anti-VEGF therapy, controlling recurrent non-ischaemic MO with an intravitreal steroid and applying laser therapy to non-perfused retina. We describe our 12-month follow-up experience on timing for adjunctive therapy and real-world effectiveness and safety data.MethodsA retrospective analysis was carried out on 66 consecutive treatment-naive RVO patients with MO who received our RandOL treatment regimen. Baseline visual acuity (VA) and central retinal thickness (CRT) were compared with 12-month result.ResultsAt 12 months, 77% had significant VA improvement, 52% had ≥3-line improvement, and 15% were worse. Significant improvements in CRT were observed in 97% (baseline median CRT=531 μm (IQR 435-622) reduced to 245 μm (IQR 221-351, P |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink